Sign in

You're signed outSign in or to get full access.

HH

HG Holdings, Inc. (STLY)·Q4 2017 Earnings Summary

Executive Summary

  • Q4 2017 revenue was approximately $11.9M, with net loss revised from approximately $6.7M to approximately $7.5M after additional slow‑moving inventory charges; losses were driven by non‑recurring items (inventory write‑downs, CEO departure costs, and transaction expenses) .
  • The company amended the asset sale terms and initiated a 14‑day go‑shop (extendable 16 days for an excluded party), reducing the termination fee to $375K during the period; closing was targeted for Q1 2018 and ultimately occurred on March 2, 2018 .
  • Prior quarters showed improving gross margins and brief profitability (Q2), with stock availability and order fulfillment materially improved by Q3 (88% orders shipped within two days), but cash pressures and inventory levels remained elevated .
  • No Q4 earnings call transcript was found; Wall Street consensus estimates from S&P Global were unavailable due to access limits, so beats/misses vs street cannot be assessed.

What Went Well and What Went Wrong

What Went Well

  • Stock availability and fulfillment improved significantly by Q3: “over the past thirty days…88% of orders were fulfilled in an average of less than two days,” with October sales up ~8% YoY .
  • Sequential improvements in sales, gross profit, and income in Q2: “signs of an inflection point…another quarter of sequential improvements,” with net income of $14K .
  • Gross margins improved vs prior year (Q2: 23.5%; Q3: 22.4%) due to reduced discounting and better absorption at higher sales levels .

What Went Wrong

  • Q4 net loss escalated after an additional ~$0.8M obsolete inventory charge, revising loss to $7.5M; earlier Q4 loss ($6.7M) already included ~$3.3M inventory charges, ~$1.7M CEO/director departure costs, and ~$0.8M transaction expenses .
  • Liquidity constraints: revolving credit borrowing capacity was capped at $2M pending asset sale closing (extended to March 15, 2018), reflecting tight financing conditions .
  • Elevated inventory and cash strain: Q3 cash fell to $1.9M, with inventory jumping to $25.4M due to overdue production shipments; year‑end cash declined to $0.975M, with accounts payable rising to $9.252M .

Financial Results

MetricQ2 2017Q3 2017Q4 2017
Revenue ($USD Millions)$11.615 $10.427 ~$11.9
Net Income ($USD Millions)$0.014 -$0.305 ~-$6.7 → ~-$7.5
Diluted EPS ($USD)$0.00 -$0.02 n/a (not disclosed)
Gross Margin (%)23.5% 22.4% n/a (not disclosed)

KPIs and Balance Sheet (end of period):

KPIQ2 2017Q3 2017Q4 2017 (Dec 31)
Cash and Equivalents ($M)$4.532 $1.236 $0.975
Restricted Cash ($M)$0.631 $0.631 $0.631
Accounts Receivable, net ($M)$4.561 $3.865 $3.146
Inventory, net ($M)$20.930 $25.381 $23.231
Accounts Payable ($M)$5.687 $6.609 $9.252

Notes:

  • Q4 results were described as preliminary in January and updated in late February ahead of year‑end audit completion .
  • No segment breakdown was disclosed in the quarter’s press materials.

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Q4 Net LossQ4 2017~-$6.7M (Jan 23 prelim) ~-$7.5M (Feb 27 update) Lowered/worsened
Asset Sale TimingQ1 2018Expected close in Q1 2018 Closed March 2, 2018 Achieved
Go‑shop/Termination FeeJan–Feb 2018$750K fee $375K during go‑shop period Reduced
Credit Facility ConstraintThrough Mar 15, 2018$2M borrowing cap until Feb 28, 2018 Extended to Mar 15, 2018 Extended timeline

Earnings Call Themes & Trends

No Q4 earnings call transcript was found.

TopicPrevious Mentions (Q2, Q3)Current Period (Q4)Trend
Supply chain & stock availabilityQ2: sourcing issues; inventories rising due to in‑transit production . Q3: 88% orders fulfilled <2 days; October sales +~8% YoY .Additional inventory write‑downs; asset sale execution .Operational availability improved by Q3; Q4 cleanup and strategic pivot.
Product performanceQ2: new introductions began selling late in quarter . Q3: demand recovery indicated by October growth .Not discussed in Q4 press release.Improving into Q3; overshadowed by Q4 restructuring.
LicensingQ3: Coastal Living® license not renewed; ~$10.0M FY16 and $8.2M 9M’17 sales under license .Not discussed.License exit continuing.
Financing/liquidityQ2: debt‑free, sufficient cash then . Q3: cash down, revolver to support lag .Revolver capped at $2M pending close ; year‑end cash $0.975M .Tightening liquidity ahead of sale.
CDSOA proceedsQ3: none; prior year had $1.103M . Q2: none .Q4: includes $0.433M in CDSOA in prelim; full‑year $0.4M .Declining vs prior year.
Strategic alternativesQ2: Stephens engagement ended; board continues evaluating .Asset sale amended (price mix, go‑shop) and closed .Concluded with sale in early March.

Management Commentary

  • “We continue to see the signs of an inflection point in the recovery of our business with another quarter of sequential improvements in sales, gross profits and income.” (Glenn Prillaman, Q2 press release) .
  • “Over the past thirty days our customers are experiencing the improvements in stock availability as 88% of orders were fulfilled in an average of less than two days. October was the company’s first month…when stock availability served customers as expected.” (Glenn Prillaman, Q3 press release) .
  • Q4 press communications focused on transaction terms and non‑recurring charges rather than operating commentary (inventory, executive transition, transaction expenses) .

Q&A Highlights

No Q4 earnings call transcript was found; therefore, there are no Q&A highlights or guidance clarifications to report.

Estimates Context

  • Wall Street consensus estimates (EPS and revenue) from S&P Global were unavailable due to access limits at the time of retrieval, so a beat/miss analysis versus consensus cannot be provided.
  • Given the magnitude and non‑recurring nature of Q4 charges (inventory, separation, transaction), street comparisons, if any, would likely have required material post‑reporting adjustments .

Key Takeaways for Investors

  • Q4 was dominated by non‑recurring restructuring costs, pushing the quarter into a larger‑than‑initially‑expected loss; the loss revision signals inventory quality clean‑up was more extensive than first anticipated .
  • Underlying operations showed margin recovery and improved fulfillment by Q3, but liquidity tightened into year‑end as inventory and payables rose and cash fell; financing flexibility was limited ahead of close .
  • The asset sale amended consideration mix (cash at least $7M, subordinated note, 5% equity) and governance terms (go‑shop, reduced termination fee), and closed on March 2—catalyzing a strategic pivot toward non‑furniture assets and potential NOL utilization .
  • With no Q4 call and estimates unavailable, near‑term trading was likely driven by transaction milestones and revised loss disclosure rather than operating beats/misses.
  • Post‑close capital allocation shifted to stock repurchases over a special dividend, with cash reserved for acquisitions; investors should watch for deal announcements and any rights offering execution to assess NOL strategy and balance sheet trajectory .
  • Operational KPIs (inventory levels, receivables, payables) at year‑end suggest a working capital reset post‑sale will be critical to assess residual liabilities and cash runway until acquisitions materialize .
  • For medium‑term thesis, evaluate management’s ability to deploy cash into accretive, non‑furniture targets leveraging NOLs, while monitoring any cash constraints and subordinated note realizations from the buyer .